
GlaxoSmithKline plc has reached an agreement with Pfizer Inc to combine their consumer health businesses into a new world-leading Joint Venture, with combined sales of approximately £9.8 billion ($12.7 billion). The JV will operate globally under the GSK Consumer Healthcare name. Under the terms of the transaction, GSK will have a majority controlling equity interest…